Universität zu Köln

Journal Article

Azad, Arun, Saad, Fred, Chowdhury, Simon, Shore, Neal, Higano, Celestia, Fizazi, Karim, Iversen, Peter, Miller, Kurt, Heidenreich, Axel, Kim, Choung Soo, Phung, De, Krivoshik, Andrew, Wang, Fong and Tombal, Bertrand (2017). FATIGUE IN MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER TREATED WITH ENZALUTAMIDE: DATA FROM RANDOMIZED CLINICAL TRIALS. Asia-Pac. J. Clin. Oncol., 13. S. 41 - 42. HOBOKEN: WILEY. ISSN 1743-7563

Beer, Tomasz M., Chowdhury, Simon, Saad, Fred, Shore, Neal D., Higano, Celestia S., Iversen, Peter, Fizazi, Karim, Miller, Kurt, Heidenreich, Axel, Kim, Choung Soo, Phung, De, Barrus, Jeffrey Kent, Nikolayeva, Natalia, Krivoshik, Andrew, Waksman, Javier and Tombal, Bertrand F. (2018). Hepatic effects assessed by review of safety data in enzalutamide castration-resistant prostate cancer (CRPC) trials. J. Clin. Oncol., 36 (6). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Cash, Hannes ORCID: 0000-0002-1064-5633, Steiner, Ursula, Heidenreich, Axel, Klotz, Theodor, Albers, Peter, Melchior, Sebastian, Martus, Peter, Fuller, Florian, Magheli, Ahmed, Hinz, Stefan, Kempkensteffen, Carsten and Miller, Kurt (2018). Intermittent vs continuous docetaxel therapy in patients with metastatic castration-resistant prostate cancer - a phase III study (PRINCE). BJU Int., 122 (5). S. 774 - 783. HOBOKEN: WILEY. ISSN 1464-410X

Cash, Hannes, Steiner, Ursula, Heidenreich, Axel, Klotz, Theodor, Melchior, Sebastian, Albers, Peter ORCID: 0000-0002-1747-9615, Martus, Peter, Hinz, Stefan, Magheli, Ahmed, Kempkensteffen, Carsten and Miller, Kurt (2016). PRINCE: A phase III study comparing intermittent docetaxel therapy versus continuous docetaxel therapy in patients with castration-resistant prostate cancer. J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Crawford, E. David, Heidenreich, Axel, Lawrentschuk, Nathan, Tombal, Bertrand, Pompeo, Antonio C. L., Mendoza-Valdes, Arturo, Miller, Kurt, Debruyne, Frans M. J. and Klotz, Laurence (2019). Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations. Prostate Cancer Prostatic Dis., 22 (1). S. 24 - 39. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5608

Harbeck, Nadia, Schneeweiss, Andreas, Thuss-Patience, Peter, Miller, Kurt, Garbe, Claus ORCID: 0000-0001-8530-780X, Griesinger, Frank, Eberhardt, Wilfried E. E., Klussmann, Jens P., Wollenberg, Barbara, Grimm, Marc-Oliver, Zander, Thomas and Lueftner, Diana (2021). Neoadjuvant and adjuvant end-points in health technology assessment in oncology. Eur. J. Cancer, 147. S. 40 - 51. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Heidenreich, Axel, Gillessen, Silke ORCID: 0000-0001-5746-6555, Heinrich, Daniel, Keizman, Daniel, O'Sullivan, Joe M., Carles, Joan, Wirth, Manfred, Miller, Kurt, Reeves, John, Seger, Monica, Nilsson, Sten and Saad, Fred (2019). Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program. BMC Cancer, 19. LONDON: BMC. ISSN 1471-2407

Rudolph, Madhuri M., Baur, Alexander D. J., Haas, Matthias, Cash, Hannes, Miller, Kurt, Mahjoub, Samy ORCID: 0000-0001-5151-1853, Hartenstein, Alexander, Kaufmann, David, Rotzinger, Roman, Lee, Chau Hung, Asbach, Patrick, Hamm, Bernd and Penzkofer, Tobias (2020). Validation of the PI-RADS language: predictive values of PI-RADS lexicon descriptors for detection of prostate cancer. Eur. Radiol., 30 (8). S. 4262 - 4272. NEW YORK: SPRINGER. ISSN 1432-1084

Saad, Fred, Carles, Joan ORCID: 0000-0002-9983-5934, Gillessen, Silke ORCID: 0000-0001-5746-6555, Heidenreich, Axel, Heinrich, Daniel, Gratt, Jeremy, Levy, Jeremy, Miller, Kurt, Nilsson, Sten, Petrenciuc, Oana, Tucci, Marcello, Wirth, Manfred, Federhofer, Judith and O'Sullivan, Joe M. (2016). Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial. Lancet Oncol., 17 (9). S. 1306 - 1317. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Saad, Fred, Gillessen, Silke ORCID: 0000-0001-5746-6555, Heinrich, Daniel, Keizman, Daniel, O'Sullivan, Joe M., Nilsson, Sten, Miller, Kurt, Wirth, Manfred, Reeves, John, Seger, Monica, Carles, Joan and Heidenreich, Axel (2019). Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access Program. Clin. Genitourin. Cancer, 17 (5). S. 348 - 361. DALLAS: CIG MEDIA GROUP, LP. ISSN 1938-0682

Smith, Matthew, Parker, Chris, Saad, Fred, Miller, Kurt, Tombal, Bertrand, Ng, Quan Sing, Boegemann, Martin, Matveev, Vsevolod, Piulats, Josep Maria, Zucca, Luis Eduardo, Karyakin, Oleg, Kimura, Go ORCID: 0000-0003-0088-9324, Matsubara, Nobuaki, Nahas, William Carlos, Nole, Franco, Rosenbaum, Eli, Heidenreich, Axel, Kakehi, Yoshiyuki, Zhang, Amity, Krissel, Heiko, Teufel, Michael, Shen, Junwu, Wagner, Volker and Higano, Celestia (2019). Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol., 20 (3). S. 408 - 420. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488